Clinical Trials Browser

Carcinoma, Hepatocellular, Liver Cirrhosis

Carcinoma, Non-Small-Cell Lung

Mouth Neoplasms

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasms, Squamous Cell

Neoplasm Metastasis, Pancreatic Neoplasms

Carcinoma, Squamous Cell, Head and Neck Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Squamous Cell Carcinoma of Head and Neck

Carcinoma, Non-Small-Cell Lung

Leukemia, Myelomonocytic, Acute

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms

Breast Neoplasms

Carcinoma, Hepatocellular, Liver Neoplasms

Carcinoma, Non-Small-Cell Lung

Colonic Neoplasms

Biliary Tract Neoplasms

Carcinoma, Non-Small-Cell Lung

Esophageal Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Adenocarcinoma Of Esophagus, Neoplasm Metastasis

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Pancreatic Neoplasms

Breast Neoplasms

Pancreatic Neoplasms

Lung Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

EGFR Exon 19 Deletion Mutation

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung

Urinary Bladder Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

Polycythemia Vera

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Prostatic Neoplasms

Urinary Bladder Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Pancreatic Neoplasms

Squamous Cell Carcinoma of Head and Neck

Carcinoma, Non-Small-Cell Lung

Esophageal Neoplasms

Relapsed Pediatric Solid Tumor

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Colorectal Neoplasms

Carcinoma, Non-Small-Cell Lung

Clinical Trials

ECHO-B

Erlotinib With or Without Hydroxychloroquine in Chemo-Naive Advanced NSCLC and (EGFR) Mutations

ProTarget

Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Oral Cavity Cancer in a Rural Midwest United States Population

OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer

Erlotinib and RAD001 (Everolimus) in Patients With Previously Treated Advanced Pancreatic Cancer

Trial of RAD001 and Erlotinib With Recurrent Head and Neck Squamous Cell Carcinoma

A Study of Erlotinib Plus Radiotherapy (RT) for Patients With Advanced or Inoperable Non-Small-Cell Lung Cancer

PIKACHU

Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck

Combination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck

Erlotinib Combined With Chemotherapy in TKI Resistant Non-Small Cell Lung Cancers

Pilot Study of Erlotinib for the Treatment of Patients With de Novo Acute Myeloid Leukemia

BLISS

ROME

Phase II Open-Label Trial of Tarceva in Women With Metastatic, Hormone- and HER2-Negative Breast Cancer

Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line Therapy

NSCLC

Pemetrexed Plus Tarceva as Salvage Treatment in EGFR Overexpressed Metastatic Colorectal Cancer Patients Who Were Failed After Standard Chemotherapy

Pemetrexed in Combination With Erlotinib as a Salvage Treatment in Patients With Metastatic Biliary Tract Cancer (BTC) Who Failed Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study

Sorafenib/Erlotinib Versus Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC)

Efficacy and Safety of Precision Therapy in Refractory Tumor

Chemotherapy, Radiation Therapy and Immunotherapy Prior to Surgery in Operable Esophageal Cancer

BATTLE-2 Program: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer

Study of Erlotinib and Chemotherapy for Unresectable or Metastatic Cancer of the Esophagus and Gastric Cardia

Tarceva With Whole Brain Radiation Therapy - Brain Mets From Non-Small Cell Lung Cancer

GEM

Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy

ThoRaT

Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

LADIE

TARLAL

Erlotinib Hydrochloride With or Without Bevacizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations

NVALT10

Pemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV or Recurrent Non-Small Cell Lung Cancer

Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial Cancer

OSI-TAR-766

Erlotinib and SBRT in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer

Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer

EVENT

ANSWER

ChemoRT With Adjuvant Chemo in Pancreatic Cancer (TARCEVA)

Erlotinib Hydrochloride and Radiation Therapy in Stage III-IV Squamous Cell Cancer of the Head and Neck

Study of OSI-774 (Tarceva) in Previously Untreated Elderly Lung Cancer Patients

Chemotherapy & Erlotinib in Treating Patients w/ Esophageal or Gastroesophageal Cancer That Cannot Be Removed by Surgery

Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy

BATTLE Program: Tarceva and Targretin in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Pemetrexed and Erlotinib for Metastatic Colorectal Cancer

OSI-774 (Erlotinib, Tarceva) in Elderly Patients